What is the role of systemic corticosteroids in the treatment of Stevens-Johnson syndrome (SJS)?

Updated: Jan 17, 2019
  • Author: C Stephen Foster, MD, FACS, FACR, FAAO, FARVO; Chief Editor: Andrew A Dahl, MD, FACS  more...
  • Print
Answer

The use of systemic corticosteroids is controversial, but may be useful in high doses early in the disease. Morbidity and mortality may actually increase in association with corticosteroid use. For persistent or recurrent ocular inflammation, patients may benefit from short-term systemic corticosteroids and/or long-term immunosuppressive therapy, which may reduce severity of conjunctivitis and improve prognosis quod visum by reducing damage to ocular surface.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!